John Burke, MD
MRD (minimal/measurable residual disease) testing is changing the way doctors understand and monitor blood cancers. In this episode, we talk with Dr. John Burke of the Rocky Mountain Cancer Center about how MRD testing works, what the results mean to patients and their care teams, and how ongoing clinical research is helping shape more personalized and hopeful approaches to treatment.
Podcast: Play in new window | Download
Subscribe: Spotify | Pandora | Blubrry | Podchaser | More
CLICK HERE to participate in our episode survey.Mentioned on this episode:
- Minimal/Measurable Residual Disease (MRD) fact sheet
- Minimal/Measurable Residual Disease (MRD) chart
- CAR T-cell therapy
Additional LLS Support Resources:
- Free Nutrition Consultations
- Information Specialists
- Free telephone/web patient programs
- Clinical Trial Support Center
- Advocacy and Public Policy
- Free booklets
- Financial support
- Young Adult Resources
- Support groups
- Survivorship Workbook
- Community
- Caregiver support
- Caregiver Workbook
- Mental Health Resources
Supported by Adaptive Biotechnologies Corporation and Allogene Therapeutics.